查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1927376

週边血管减容器械市场依产品类型、临床适应症、入路部位、最终用户及通路划分－2026-2032年全球预测

Peripheral Vascular Debulking Device Market by Product Type, Clinical Indication, Access Site, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，週边血管减容装置市值将达到 117.2 亿美元，到 2026 年将成长至 125.1 亿美元，到 2032 年将达到 188.9 亿美元，年复合成长率为 7.05%。

关键市场统计数据
基准年 2025 117.2亿美元
预计年份：2026年 125.1亿美元
预测年份 2032 188.9亿美元
复合年增长率 (%) 7.05%

本文策略性地介绍了影响週边血管减容装置应用的临床背景、技术发展历程和采购考量。

週边血管斑块消融装置在介入性心臟病学和血管外科的交叉领域占据着至关重要的地位，它们能够靶向斑块修饰和病变准备，从而改善血管通畅性和手术效果。装置动态、影像整合和导管设计的进步不断拓展了这些系统的临床效用，使临床医生能够治疗週边和肾臟血管系统中更广泛的复杂动脉粥状硬化病变。临床团队在选择动脉粥状硬化斑块切除术术时，通常会评估斑块形态、钙化负荷和病灶长度。同时，手术流程也越来越重视血管通路策略以及术前术后影像检查，以优化治疗效果并减少併发症。

深入剖析重塑医疗设备工程、临床工作流程和价值论证的关键趋势

随着临床需求、器材创新和医疗系统优先事项的整合，週边血管减容器械领域正在迅速变化，产品价值提案也随之重新定义。影像导引的手术规划和术中指导正在重塑临床医生的选择偏好，而高解析度血管内成像和融合技术则能够更精确地评估病变并进行靶向减容。器械设计也在不断演进，从单一用途的导管发展到可相容辅助性治疗并提高多入路输送能力的平台型设计。

对2025年关税环境如何重塑设备相关人员的采购、定价策略与供应链韧性进行全面分析

2025年关税政策的实施为週边血管器械采购引入了新的变数，促使製造商和医疗系统重新评估筹资策略和成本结构。随着零件和成品进口关税的提高，製造商纷纷评估双重采购安排和区域供应替代方案，以缓解利润压力。这种被动的资源重新配置往往导致短期营运调整，例如增加库存缓衝、选择性地本地化高价值零件以及重新谈判供应商合同，以在保持品质标准的同时维持价格竞争力。

详细的細項分析揭示了产品机制、临床适应症、医疗环境、分销模式和获取策略如何共同决定了产品的采用趋势。

对产品层面、终端用户、临床、分销和手术途径等细分领域的深入分析揭示了技术应用的实际机会和限制因素。按产品类型进行差异化仍然至关重要。定向动脉粥状硬化斑块切除术装置，例如 SilverHawk 和 TurboHawk，专注于针对软性纤维斑块病变的靶向斑块消融；而激光系统，例如准分子激光和 Nd:YAG 激光，则提供适用于纤维化和血栓性闭塞的光消融机制。轨道式动脉粥状硬化斑块切除术有两种类型——传统轨道式和微振动式——由于其渐进式研磨作用，通常是重度钙化病变的首选。旋转式设备，例如 JetStream 和周边旋转消融器，可对局部钙化狭窄进行高速旋转消融。每种设备在机械性能、学习曲线、栓塞风险降低以及对辅助性治疗选择的影响方面都具有独特的特点。

决定商业性和临床成功的区域市场动态和战略要务（美洲、欧洲、中东和非洲、亚太地区）

区域趋势对週边血管技术的商业化策略、临床应用和监管反应有显着影响。在美洲，先进的临床实践模式、三级医疗中心的高手术量以及完善的报销机制共同加速了新型减量手术方式的推广应用。然而，由于公立和私立支付方的多样性，强有力的卫生经济学证据和针对性的价值提案至关重要。欧洲、中东和非洲地区（EMEA）的管理体制和采购模式各不相同。市场准入需要协调一些国家集中式的监管体系与另一些国家分散式的医院采购结构，而本地化的临床数据和经销伙伴对于技术的广泛应用至关重要。

分析竞争格局，重点在于企业策略、证据产生、伙伴关係和服务模式。

该领域的竞争格局呈现出成熟平台供应商、专业化利基创新者和日益增多的新兴企业之间的平衡，这些新创公司致力于推进新型消融机制和整合成像解决方案。现有企业通常利用其广泛的服务网络、临床培训平台以及与医院系统的长期合作关係来巩固其首选供应商地位，而利基企业则透过设备特定的性能声明、简化的手术流程或针对特定适应症的临床证据来脱颖而出。新兴企业通常透过专注于迭代改进来建立临床地位，例如降低栓塞风险、提高器械到达难入路部位的可行性以及最大限度地减少对操作者的依赖性。

为製造商和供应商提供可操作的策略性倡议，以加速产品应用、强化价值链并展现临床和经济价值。

产业领导者应优先采取一系列协调一致的策略行动，将产品开发、临床证据和商业性执行有机结合，以最大限度地提高产品应用率和实现长期价值。首先，他们应投资于高品质的临床证据，这些证据应能将器械选择与手术成功率、肢体挽救率和降低再次干预率等重要终点直接联繫起来，并优先开展能够引起支付方和指南委员会共鸣的前瞻性註册研究和比较研究。其次，他们应加强培训和认证项目，以缩短学习曲线，并使介入性心臟病学和血管外科团队的技术标准化，从而减少结果差异，增强临床医生的信心。

对用于得出基于证据的策略见解的多源研究框架、同行检验流程和分析保障措施进行透明描述

本分析的调查方法结合了多方面的证据收集、同行检验和迭代三角测量，从而得出可靠且可操作的结论。辅助研究活动包括对同行评审的临床文献进行系统性回顾、分析监管申报和医疗设备认证、评估临床实践指南以及评估手术编码和报销框架，以支持临床和商业性背景。主要研究包括对介入性心臟病专家、血管外科医生、采购负责人和分销合作伙伴进行结构化访谈，以了解他们对医疗设备性能、培训需求和采购因素的细緻看法。

一份权威的综合分析报告，重点阐述了证据、营运韧性和跨职能策略在实现临床和商业性成功方面发挥的关键作用。

一项综合分析表明，週边血管减容装置正处于一个关键的转折点，技术改进、循证医学证据的累积以及与之匹配的商业模式将决定其未来的应用模式。装置动态的进步以及与影像技术的整合拓展了其临床应用范围，但要在多种医疗环境中充分证明其安全性、有效性和成本效益，才是实现广泛应用的关键。供应链的波动和政策的变化日益凸显了营运韧性的重要性，迫使製造商和医疗系统重新评估其采购和合约策略。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 週边血管减容装置市场（依产品类型划分）

  • 定向斑块动脉粥状硬化斑块切除术
    • 银鹰
    • 涡轮鹰
  • 雷射动脉动脉粥状硬化斑块切除术
    • 准分子雷射
    • Nd:YAG雷射
  • 轨道动脉粥状动脉粥状硬化斑块切除术
    • 常规轨道
    • 微振动型
  • 旋切动脉粥状硬化斑块切除术
    • 急流
    • 末梢用旋转器

9. 週边血管减容器械市场（依临床适应症划分）

  • 颈动脉狭窄
  • 严重肢体缺血
  • 周边动脉疾病
  • 肾动脉狭窄

第十章 週边血管减容器械市场（依入路部位划分）

  • 肱动脉路
  • 股动脉路径
  • 径向通道

第十一章 外周血管减容器械市场（按最终用户划分）

  • 门诊手术中心
  • 诊所
  • 医院
    • 循环系统
    • 血管外科

第十二章 週边血管减容器械市场（依通路划分）

  • 直销
  • 批发的

13. 週边血管减容器械市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 週边血管减容器械市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国外周血管减容器械市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

16. 美国週边血管减容器械市场

第十七章 中国外周血管减容器械市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Avinger, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Cook Medical LLC
  • Koninklijke Philips NV
  • Medtronic plc
  • Straub Medical Group AG
  • Terumo Corporation
Product Code: MRR-4F7A6D4FF384

The Peripheral Vascular Debulking Device Market was valued at USD 11.72 billion in 2025 and is projected to grow to USD 12.51 billion in 2026, with a CAGR of 7.05%, reaching USD 18.89 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.72 billion
Estimated Year [2026] USD 12.51 billion
Forecast Year [2032] USD 18.89 billion
CAGR (%) 7.05%

A strategic introduction outlining clinical context, technological evolution, and procurement imperatives shaping peripheral vascular debulking device adoption

Peripheral vascular debulking devices occupy a critical niche at the intersection of interventional cardiology and vascular surgery, providing targeted plaque modification and lesion preparation to improve vascular patency and procedural outcomes. Advances in device mechanics, imaging integration, and catheter design have progressively expanded the clinical utility of these systems, enabling clinicians to treat a broader spectrum of complex atherosclerotic lesions across peripheral and renal vasculature. Clinical teams now routinely evaluate plaque morphology, calcification burden, and lesion length when selecting an atherectomy modality, while procedural workflows increasingly prioritize vascular access strategy and peri-procedural imaging to optimize outcomes and reduce complications.

Against this clinical backdrop, stakeholders across industry, hospital procurement, and clinical practice face converging pressures to demonstrate value through procedural efficiency, consistent clinical outcomes, and alignment with evolving reimbursement and regulatory expectations. Technology roadmaps emphasize modular platforms, compatibility with adjunctive devices, and integrated data capture to support post-market evidence generation. Consequently, purchasers are weighing capital acquisition against service models and vendor-supported training. As new device generations emerge with refined mechanisms for calcified lesion modification and embolic protection integration, evaluating clinical differentiation, training burden, and supply chain resilience becomes essential for those seeking to adopt or expand the use of debulking technologies.

An incisive exploration of the major transformative trends reshaping device engineering, clinical workflows, and value demonstration across care settings

The landscape for peripheral vascular debulking devices is shifting rapidly as clinical expectations, device innovation, and health system priorities converge to redefine product value propositions. Imaging-driven procedural planning and intra-procedural guidance are reshaping operator preferences, with high-resolution intravascular imaging and fusion techniques enabling more precise lesion assessment and targeted debulking. Device designs continue to evolve from single-purpose catheters toward platform approaches that accommodate adjunctive therapies and provide improved deliverability across varied access sites.

Concurrently, care delivery models are moving procedures out of traditional inpatient settings into ambulatory surgery centers and hybrid suites, accelerating demand for devices that minimize procedural time and enable same-day discharge. This shift elevates the importance of robust training programs and simplified procedural workflows that reduce variability in operator performance. In parallel, emphasis on peri-procedural safety has intensified, leading to broader adoption of embolic protection strategies, adjunctive imaging, and post-procedural surveillance protocols. On the commercial front, manufacturers are responding with expanded service offerings, bundled contracting options, and digital tools that surface real-world performance metrics. Taken together, these transformative shifts are not only altering how devices are designed and used, but also how value is demonstrated to payers, providers, and patients.

A comprehensive analysis of how the 2025 tariff environment reshaped sourcing, pricing strategies, and supply chain resilience for device stakeholders

Tariff measures enacted in 2025 introduced a new variable into the procurement calculus for peripheral vascular devices, prompting manufacturers and health systems to reassess sourcing strategies and cost structures. Where component and finished-device imports were subject to increased duties, manufacturers expedited evaluation of dual-sourcing arrangements and regional supply alternatives to mitigate margin erosion. This reactive repositioning often translated into near-term operational adjustments such as increased inventory buffers, selective localization of high-value components, and renegotiation of supplier contracts to preserve price competitiveness while maintaining quality standards.

The cumulative effect extended to distribution channels and end users who experienced shifts in price transparency and procurement timelines. Hospitals and ambulatory centers faced intensified scrutiny over device selection, with purchasing committees requesting more comprehensive total-cost-of-ownership analyses and service-inclusive contracting to offset apparent unit cost increases. In response, some manufacturers accelerated investment in domestic assembly or contract manufacturing partnerships to reduce tariff exposure and demonstrate supply reliability. Regulatory and reimbursement dynamics also influenced behavior, as payers scrutinized any effective cost increases against clinical benefit. Overall, the tariff environment catalyzed a broader strategic realignment, encouraging supply chain diversification, tightened supplier relationships, and a renewed emphasis on operational resilience and commercial models that protect access while managing incremental cost pressure.

Detailed segmentation insights revealing how product mechanics, clinical indication, care setting, distribution model, and access strategy collectively determine adoption dynamics

Insight into product-level, end-user, clinical, distribution, and procedural access segmentation illuminates practical opportunities and constraints for technology diffusion. Product type differentiation remains foundational: directional atherectomy options such as platforms typified by SilverHawk and TurboHawk emphasize targeted plaque excision for soft and fibroatheromatous lesions, while laser-based systems, including Excimer Laser and Nd:YAG variants, offer photoablative mechanisms suited to fibrotic and thrombotic occlusions. Orbital atherectomy, available in conventional orbital and micro-oscillating designs, is often selected for its capacity to modify heavily calcified lesions with differential sanding action, whereas rotational modalities like Jetstream and Peripheral Rotablator deliver high-speed rotational ablation for focal calcified stenoses. Each modality carries distinct mechanical profiles, learning curves, and implications for embolic risk mitigation and adjunctive therapy selection.

End-user segmentation likewise influences adoption patterns: hospitals with dedicated cardiology and vascular surgery departments tend to be early adopters of advanced debulking technologies because of case complexity and procedural volume, whereas ambulatory surgery centers and clinics prioritize devices that support same-day throughput and streamlined logistics. Clinical indications drive device selection as well; carotid artery stenosis, critical limb ischemia, peripheral artery disease, and renal artery stenosis each present unique lesion morphologies and access considerations. Distribution channel dynamics-direct sales versus distributor networks-shape post-sale support, training, and bundled service offerings, while procedural access site choices such as brachial, femoral, and radial access impact device shaft design, catheter length, and sheath compatibility. Understanding how these segmentation layers interact provides actionable insight into where investment in evidence, training, and distribution will most effectively translate into adoption and clinical impact.

Regional market dynamics and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine commercial and clinical success

Regional dynamics exert a pronounced effect on commercialization strategies, clinical adoption, and regulatory navigation for peripheral vascular technologies. In the Americas, a combination of advanced clinical practice patterns, high procedure volumes in tertiary centers, and progressive reimbursement frameworks often accelerates uptake of novel debulking modalities, though private and public payer heterogeneity necessitates strong health economic evidence and targeted value propositions. Europe, the Middle East & Africa presents a mosaic of regulatory regimes and procurement models; market entry efforts must reconcile centralized regulation in some countries with decentralized hospital purchasing in others, making localized clinical data and distribution partnerships essential to scaling adoption.

In the Asia-Pacific region, rapid investment in interventional infrastructure and an expanding base of trained operators create significant runway for device penetration, but success requires attentiveness to manufacturing cost structures, regulatory timelines, and local clinical practice variations. Across all regions, translation of clinical innovation into sustainable adoption depends on aligning training, service support, and evidence generation with the unique procurement cadences and clinical priorities of each geography. Manufacturers that tailor commercial and clinical strategies to the regulatory contours and care-delivery models of each region stand a greater chance of achieving sustained engagement with healthcare providers and payers.

Competitive landscape analysis highlighting company strategies, evidence generation, partnerships, and service models that drive market differentiation

Competitive dynamics in this segment reflect a balance between established platform providers, specialized niche innovators, and an increasing number of agile startups advancing novel ablative mechanisms and integrated imaging solutions. Established firms typically leverage broad service networks, clinical training infrastructure, and long-term relationships with hospital systems to secure preferred-vendor status, while niche players differentiate through device-specific performance claims, simplified procedural workflows, or targeted clinical evidence in specialized indications. Emerging companies often focus on iterative improvements-reducing embolic risk, improving deliverability for challenging access sites, or minimizing operator-dependent variability-to carve clinical footholds.

Strategic imperatives for companies include expanding evidence portfolios through prospective registries and randomized comparisons, enhancing post-market surveillance capabilities, and developing service models that reduce the training burden for new operators. Partnerships with imaging vendors, consumable suppliers, and contract manufacturers are increasingly common as firms seek to offer integrated solutions and manage capital intensity. Mergers and acquisitions activity tends to center on acquiring complementary technology, consolidating distribution channels, or adding clinical capabilities that accelerate market penetration. For investors and corporate strategists, the most salient company-level indicators are the depth of clinical evidence, the robustness of post-sale service, and the flexibility of commercial models to meet diverse hospital and outpatient needs.

Actionable strategic initiatives for manufacturers and providers to accelerate adoption, strengthen supply chains, and demonstrate clinical and economic value

Industry leaders should prioritize a coordinated set of strategic actions that align product development, clinical evidence, and commercial execution to maximize uptake and long-term value capture. First, invest in high-quality clinical evidence that directly links device selection to meaningful endpoints such as procedural success, limb salvage, and reduced reintervention rates, and prioritize prospective registries and comparative studies that resonate with payers and guideline committees. Second, enhance training and credentialing programs that shorten learning curves and standardize techniques across interventional cardiology and vascular surgery teams, thereby reducing variability in outcomes and building clinician confidence.

Third, strengthen supply chain resilience through regional manufacturing partnerships, dual sourcing, and flexible inventory strategies to mitigate tariff exposure and logistical disruptions. Fourth, tailor commercial models by geography and care setting, offering bundled pricing, service-inclusive contracts, and data-driven support for hospital procurement teams to facilitate purchasing decisions. Fifth, emphasize integration with imaging and embolic protection solutions to address safety concerns and expand the range of treatable lesions. Finally, engage payers early with targeted health economic dossiers that articulate total-cost-of-care implications and support favorable reimbursement pathways. Implementing these complementary actions will help companies reduce adoption barriers, demonstrate sustainable clinical value, and secure advantageous position within evolving care pathways.

A transparent description of the multi-source research framework, expert validation processes, and analytic safeguards used to derive evidence-based strategic insights

The research methodology underpinning this analysis combined multi-source evidence collection, expert validation, and iterative triangulation to produce robust, actionable insights. Secondary research activities included systematic review of peer-reviewed clinical literature, analysis of regulatory filings and device approvals, assessment of clinical practice guidelines, and evaluation of procedural coding and reimbursement frameworks to ground clinical and commercial context. Primary research comprised structured interviews with interventional cardiologists, vascular surgeons, procurement professionals, and distribution partners to capture nuanced perspectives on device performance, training needs, and purchasing drivers.

Data synthesis employed triangulation across these sources to reconcile differences and identify consensus trends, while internal validity checks compared reported clinical outcomes with publicly available trial registries and post-market surveillance reports. Sensitivity analyses explored the operational impact of supply chain shocks and policy changes, and findings were peer-reviewed by external clinical advisors to ensure clinical plausibility and relevance. Recognized limitations include the evolving nature of clinical evidence and regional regulatory shifts that can change adoption dynamics; therefore, recommendations are presented with a focus on adaptability and monitoring protocols to update strategic assumptions as new data become available.

A conclusive synthesis highlighting the decisive role of evidence, operational resilience, and cross-functional strategy in realizing clinical and commercial success

The cumulative analysis underscores that peripheral vascular debulking devices are at an inflection point where technological refinement, evidence generation, and aligned commercial models will determine future adoption patterns. Advances in device mechanics and integration with imaging are enabling broader clinical applicability, yet adoption will hinge on convincing demonstrations of safety, efficacy, and cost-effectiveness across diverse care settings. Supply chain volatility and policy changes have raised the premium on operational resilience, prompting both manufacturers and health systems to reassess sourcing and contracting strategies.

Going forward, the organizations that succeed will be those that couple differentiated product performance with rigorous clinical evidence, scalable training programs, and flexible commercial arrangements that address the specific needs of hospitals, ambulatory centers, and clinics. Cross-functional collaboration-spanning R&D, clinical affairs, regulatory, and commercial teams-will be essential to translate innovation into repeatable clinical practice. By prioritizing these strategic levers, stakeholders can better navigate regulatory complexity, payer scrutiny, and procedural workflow constraints, ultimately improving patient outcomes while sustaining commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Vascular Debulking Device Market, by Product Type

  • 8.1. Directional Atherectomy
    • 8.1.1. SilverHawk
    • 8.1.2. TurboHawk
  • 8.2. Laser Atherectomy
    • 8.2.1. Excimer Laser
    • 8.2.2. NdYag Laser
  • 8.3. Orbital Atherectomy
    • 8.3.1. Conventional Orbital
    • 8.3.2. Micro-Oscillating
  • 8.4. Rotational Atherectomy
    • 8.4.1. Jetstream
    • 8.4.2. Peripheral Rotablator

9. Peripheral Vascular Debulking Device Market, by Clinical Indication

  • 9.1. Carotid Artery Stenosis
  • 9.2. Critical Limb Ischemia
  • 9.3. Peripheral Artery Disease
  • 9.4. Renal Artery Stenosis

10. Peripheral Vascular Debulking Device Market, by Access Site

  • 10.1. Brachial Access
  • 10.2. Femoral Access
  • 10.3. Radial Access

11. Peripheral Vascular Debulking Device Market, by End User

  • 11.1. Ambulatory Surgery Center
  • 11.2. Clinic
  • 11.3. Hospital
    • 11.3.1. Cardiology Department
    • 11.3.2. Vascular Surgery Department

12. Peripheral Vascular Debulking Device Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales

13. Peripheral Vascular Debulking Device Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Peripheral Vascular Debulking Device Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peripheral Vascular Debulking Device Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Peripheral Vascular Debulking Device Market

17. China Peripheral Vascular Debulking Device Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Avinger, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. Cardiovascular Systems, Inc.
  • 18.10. Cook Medical LLC
  • 18.11. Koninklijke Philips N.V.
  • 18.12. Medtronic plc
  • 18.13. Straub Medical Group AG
  • 18.14. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SILVERHAWK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SILVERHAWK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SILVERHAWK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY TURBOHAWK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY TURBOHAWK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY TURBOHAWK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY EXCIMER LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY EXCIMER LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY EXCIMER LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY NDYAG LASER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY NDYAG LASER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY NDYAG LASER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CONVENTIONAL ORBITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CONVENTIONAL ORBITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CONVENTIONAL ORBITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY MICRO-OSCILLATING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY MICRO-OSCILLATING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY MICRO-OSCILLATING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY JETSTREAM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY JETSTREAM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY JETSTREAM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ROTABLATOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ROTABLATOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ROTABLATOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RENAL ARTERY STENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RENAL ARTERY STENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RENAL ARTERY STENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY BRACHIAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY BRACHIAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY BRACHIAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RADIAL ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RADIAL ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CARDIOLOGY DEPARTMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CARDIOLOGY DEPARTMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CARDIOLOGY DEPARTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY VASCULAR SURGERY DEPARTMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY VASCULAR SURGERY DEPARTMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY VASCULAR SURGERY DEPARTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 243. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 245. NATO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)